Blueshift Asset Management, LLC Moderna, Inc. Transaction History

Blueshift Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$225.82 - $368.51 $248,402 - $405,361	-1,100 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$221.9 - $484.47 $6.29 Million - $13.7 Million	-28,332 Reduced 96.26%	1,100 $423,000
Q2 2021 Aug 13, 2021	BUY	$129.91 - $234.98 $3.82 Million - $6.92 Million	29,432 New	29,432 $6.92 Million
Q1 2021 May 06, 2021	SELL	$109.18 - $185.98 $978,471 - $1.67 Million	-8,962 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$65.74 - $169.86 $589,161 - $1.52 Million	8,962 New	8,962 $936,000
Q3 2020 Nov 13, 2020	SELL	$54.34 - $94.85 $718,537 - $1.25 Million	-13,223 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$29.67 - $80.0 $392,326 - $1.06 Million	13,223 New	13,223 $849,000
Q1 2020 May 14, 2020	SELL	$17.78 - $31.58 $293,761 - $521,764	-16,522 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$13.93 - $21.28 $230,151 - $351,588	16,522 New	16,522 $323,000

953

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $16.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.